OPCH vs. GILD
OPCH (Option Care Health, Inc.) and GILD (Gilead Sciences, Inc.) are both stocks. Both are in the Healthcare sector — OPCH in Medical Care Facilities, GILD in Drug Manufacturers - General. Over the past 10 years, OPCH returned 5.42%/yr vs 7.70%/yr for GILD. At a 0.16 correlation, their price movements are largely independent.
Performance
OPCH vs. GILD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OPCH achieves a -37.01% return, which is significantly lower than GILD's 5.84% return. Over the past 10 years, OPCH has underperformed GILD with an annualized return of 5.42%, while GILD has yielded a comparatively higher 7.70% annualized return.
OPCH
- 1D
- -2.24%
- 1M
- -5.77%
- YTD
- -37.01%
- 6M
- -32.87%
- 1Y
- -35.90%
- 3Y*
- -12.88%
- 5Y*
- 1.24%
- 10Y*
- 5.42%
GILD
- 1D
- 0.15%
- 1M
- -3.22%
- YTD
- 5.84%
- 6M
- 6.65%
- 1Y
- 21.64%
- 3Y*
- 22.54%
- 5Y*
- 18.21%
- 10Y*
- 7.70%
OPCH vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
OPCH Option Care Health, Inc. | -37.01% | 37.33% | -31.14% | 11.96% | 5.80% | 81.84% | 4.83% | 4.48% | 22.68% | 179.81% |
GILD Gilead Sciences, Inc. | 5.84% | 36.59% | 18.68% | -1.99% | 23.63% | 29.95% | -6.70% | 7.88% | -9.92% | 2.96% |
Correlation
The correlation between OPCH and GILD is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Aug 16, 1996 | 0.16 |
The correlation between OPCH and GILD shifts across timeframes, from 0.16 (all time) to 0.26 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
OPCH:
$3.18B
GILD:
$161.99B
OPCH:
$1.28
GILD:
$7.35
OPCH:
15.73
GILD:
17.58
OPCH:
0.87
GILD:
0.04
OPCH:
0.57
GILD:
5.45
OPCH:
2.35
GILD:
6.89
OPCH:
$5.67B
GILD:
$29.74B
OPCH:
$1.09B
GILD:
$18.74B
OPCH:
$432.01M
GILD:
$12.88B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OPCH vs. GILD — Risk / Return Rank
OPCH
GILD
OPCH vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Option Care Health, Inc. (OPCH) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| OPCH | GILD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.72 | ||
| Sortino ratioReturn per unit of downside risk | -2.46 | ||
| Omega ratioGain probability vs. loss probability | 0.83 | 1.16 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | -0.77 | 1.23 | -2.00 |
| Martin ratioReturn relative to average drawdown | -1.94 | 3.07 | -5.02 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| OPCH | GILD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.89 | 0.83 | -1.72 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | 0.76 | -0.73 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.10 | 0.30 | -0.21 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.04 | 0.39 | -0.43 |
Drawdowns
OPCH vs. GILD - Drawdown Comparison
The maximum OPCH drawdown since its inception was -95.83%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for OPCH and GILD.
Loading charts...
Drawdown Indicators
| OPCH | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.83% | -70.83% | -25.00% |
Max Drawdown (1Y)Largest decline over 1 year | -46.65% | -17.65% | -29.00% |
Max Drawdown (3Y)Largest decline over 3 years | -46.65% | -26.59% | -20.06% |
Max Drawdown (5Y)Largest decline over 5 years | -46.65% | -26.59% | -20.06% |
Max Drawdown (10Y)Largest decline over 10 years | -69.37% | -30.47% | -38.90% |
Current DrawdownCurrent decline from peak | -77.70% | -16.62% | -61.08% |
Average DrawdownAverage peak-to-trough decline | -72.14% | -22.16% | -49.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 18.50% | 7.06% | +11.44% |
Volatility
OPCH vs. GILD - Volatility Comparison
Option Care Health, Inc. (OPCH) has a higher volatility of 12.83% compared to Gilead Sciences, Inc. (GILD) at 7.26%. This indicates that OPCH's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OPCH | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.83% | 7.26% | +5.57% |
Volatility (6M)Calculated over the trailing 6-month period | 37.08% | 18.55% | +18.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.31% | 26.31% | +14.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.17% | 24.03% | +15.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 56.10% | 25.49% | +30.61% |
Dividends
OPCH vs. GILD - Dividend Comparison
OPCH has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 2.47%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.47% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
OPCH Option Care Health, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
OPCH vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Option Care Health, Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
OPCH vs. GILD - Profitability Comparison
OPCH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Option Care Health, Inc. reported a gross profit of 262.01M and revenue of 1.35B. Therefore, the gross margin over that period was 19.4%.
GILD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.
OPCH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Option Care Health, Inc. reported an operating income of 72.55M and revenue of 1.35B, resulting in an operating margin of 5.4%.
GILD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.
OPCH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Option Care Health, Inc. reported a net income of 45.34M and revenue of 1.35B, resulting in a net margin of 3.4%.
GILD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.
Frequently Asked Questions
OPCH and GILD have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OPCH has higher volatility (12.83%) compared to GILD (7.26%). In terms of maximum drawdown, OPCH dropped -95.83% vs GILD's -70.83%.
GILD currently has the higher Sharpe Ratio (0.83 vs -0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OPCH and GILD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer